Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

1 result

  1. SOCIAL QUESTIONS|health|pharmaceutical industry
    próifíl eisíontais Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Context 'Is le foirmliú dáileoige béil soladach tobscaoilte nó le tuaslagán béil amháin a bhainfidh an t-athrú agus ní spreagfar athrú díobhálach ar phróifíl eisíontais cáilíochta ná ar phróifíl eisíontais cainníochta ná ar airíonna fisiciceimiceacha.' Reference "Rialachán Cur Chun Feidhme (AE) 2021/17 lena mbunaítear liosta modhnuithe nach n-éilíonn measúnú i gcomhréir le Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle, CELEX:32021R0017/GA"
    impurity profile
    en
    Definition "identity of impurities, quantity of impurities and source of impurities as well as description of unidentified impurities present" Reference "COM-Terminology Coordination, based on: - EMA. 'ICH Topic Q 3 B (R2) Impurities in New Drug Products' (17.2.2023). June 2006 CPMP/ICH/2738/99- PharmTech.com. 'Evaluating Impurities in Drugs (Part III of III)' (17.2.2023)"
    Comment Concerning pharmaceutical products, there are synthesis-related impurities, formulation-related impurities, dosage form-related impurities, method-related impurities, environmental-related impurities, impurities on aging, metabolite impurities.